Elan Corp (ELN)

Currency in USD
18.12
0.00(0.00%)
Closed·
Showing Elan historical data. For real-time data please try another search
Day's Range
17.9118.20
52 wk Range
0.0018.20
Key Statistics
Prev. Close
18.12
Open
17.91
Day's Range
17.91-18.2
52 wk Range
0-0
Volume
-
Average Volume (3m)
6.61M
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Elan Corp News & Analysis

Show more

Elan Corp Company Profile

As of December 18, 2013, Elan Corporation Limited was acquired by Perrigo Company Public Limited Company. Elan Corporation Limited is a biotechnology company in the United States, Ireland, and internationally. The company develops ELND005, an orally bioavailable small molecule in Phase II clinical trial being investigated for multiple neuropsychiatric indications on the basis of its proposed dual mechanism of action, which includes b-amyloid anti-aggregation and regulation of brain myo-inositol levels. It also develops ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder to delay the time to occurrence of mood episodes; and for the treatment of agitation/aggression in patients with moderate to severe Alzheimer’s disease. Elan Corporation Limited was founded in 1969 and is headquartered in Dublin, Ireland.

Elan Corp Earnings Call Summary for Q4/2024

  • Consolidated revenues down 1.8% YoY to €565.8M; net income up 7% to €51.6M
  • Medical sector revenues grew 4%, industrial sector declined 15%; EBITDA stable at €91.8M
  • Cautious 2025 outlook: revenues expected to align with 2024 levels amid global challenges
  • Net financial position improved to €110.6M from €60M at year start
  • Risks include international conflicts, interest rate changes, weakening USD, and loss of Cynosure revenues
Last Updated: 14/03/2025, 15:38
Read Full Transcript

Earnings

Latest Release
Feb 06, 2019
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ELN Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.